- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
In Parkinson's, dementia may occur less often, or later, than thought, reports study
There's some good news for people with Parkinson's disease: The risk of developing dementia may be lower than previously thought, or dementia may occur later in the course of the disease than previously reported, according to a study published in the August 7, 2024, online issue of Neurology, the medical journal of the American Academy of Neurology.
“The development of dementia is feared by people with Parkinson’s, and the combination of both a movement disorder and a cognitive disorder can be devastating to them and their loved ones,” said study author Daniel Weintraub, MD, of the University of Pennsylvania in Philadelphia. “These results provide more hopeful estimates of the long-term risk of dementia for people with Parkinson’s disease, suggesting that there is a longer window to intervene to prevent or delay cognitive decline.”
Previous studies had indicated that about 80% of people with Parkinson’s disease would develop dementia within 15-20 years after being diagnosed with Parkinson’s.
“While these studies were important in highlighting the issue of cognitive decline in Parkinson’s disease, the studies were conducted many years ago, were relatively small and had other limitations, so we wanted to re-evaluate these findings,” Weintraub said.
For the study, researchers analyzed data from two large, prospective studies. An international study involved 417 participants with an average age of 62 who were newly diagnosed with Parkinson’s disease and had not yet received treatment for the disease at study enrollment. A study at the University of Pennsylvania involved 389 people with Parkinson’s with an average age of 69 who had been diagnosed with Parkinson’s an average of six years before the start of the study. The participants were followed to see whether they developed dementia.
The international study showed an estimated probability of being diagnosed with dementia 10 years after being diagnosed with Parkinson’s disease of 9%. For the Pennsylvania study, the probability of being diagnosed with dementia 10 years after the Parkinson’s diagnosis was 27%. For the latter study, researchers found an estimated risk of dementia at 50%, 15 years after a Parkinson’s diagnosis and 74%, 20 years after diagnosis.
Factors that increased the risk of dementia in the Pennsylvania study included being older when Parkinson’s was diagnosed, being male and having a lower level of education.
A limitation of both studies is that participants were highly educated, mainly white people and were recruited for participation in a research study, so they may not represent the general population.
The international study, the Parkinson’s Progression Markers Initiative, is a public-private partnership funded by the Michael J. Fox Foundation for Parkinson’s Research and numerous funding partners. The University of Pennsylvania study was supported by the National Institute on Aging.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751